FDA approves 1st generic nasal spray to treat opioid overdose
U.S. regulators have approved the first generic nasal spray version of Narcan, a drug that reverses opioid overdoses. The Food and Drug Administration gave the green light Friday for naloxone spray from Israel's Teva Pharmaceuticals. "In the wake of the…